Directors of bioinformatics and of commercial insights and innovation talk about the real impact of their work in genomics
Illumina collaborated on a study presented at ASCO 2025 showing that circulating tumor DNA provides actionable data for clinical trials
Illumina bioinformatics solutions prove essential for a Northern Territory genomics program
At ESHG 2025 in Milan, Illumina welcomed customers and industry colleagues to discuss the future of genomic research and health care
| Date | Publication | Title |
|---|---|---|
| 4 Jun. 2025 | GenomeWeb | Illumina AI Team Unveils Program to Find Promoter DNA Variants Contributing to Rare Disease |
| 2 Jun. 2025 | Pharma Outlook | The Future of Genomic Sequencing: Trends That Will Define the Next Decade |
| 29 May 2025 | Medical Device Network | Illumina widens access to cancer tests with Medicare and new CDx |
| 29 May 2025 | Endpoints News | DNA giant Illumina spawned an ecosystem of competitors and customers |
| 29 May 2025 | GenomeWeb | ESHG: Studies Demonstrate Potential of Long-Read Sequencing in Rare Disease Diagnostics |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.
